Michaël Levraut

556 total citations
19 papers, 180 citations indexed

About

Michaël Levraut is a scholar working on Pathology and Forensic Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Michaël Levraut has authored 19 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 8 papers in Rheumatology and 5 papers in Molecular Biology. Recurrent topics in Michaël Levraut's work include Multiple Sclerosis Research Studies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Michaël Levraut is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Peripheral Neuropathies and Disorders (4 papers). Michaël Levraut collaborates with scholars based in France, United States and Switzerland. Michaël Levraut's co-authors include Christine Lebrun‐Frénay, Mikaël Cohen, Lydiane Mondot, Saskia Bresch, Véronique Bourg, Barbara Seitz‐Polski, Nihal Martis, Caroline Giordana, Fanny Burel‐Vandenbos and Pierre Thomas and has published in prestigious journals such as Frontiers in Immunology, Biomedicine & Pharmacotherapy and EBioMedicine.

In The Last Decade

Michaël Levraut

16 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Levraut France 9 81 66 63 43 38 19 180
Neil Shuey Australia 9 70 0.9× 22 0.3× 89 1.4× 28 0.7× 18 0.5× 22 198
P. Vermersch France 8 78 1.0× 31 0.5× 57 0.9× 26 0.6× 65 1.7× 28 247
Yaser Al Malik Saudi Arabia 9 134 1.7× 28 0.4× 49 0.8× 15 0.3× 22 0.6× 33 200
Stijn W. Genders Netherlands 9 58 0.7× 50 0.8× 66 1.0× 49 1.1× 33 0.9× 17 310
Carlo Asteggiano Italy 8 59 0.7× 19 0.3× 58 0.9× 16 0.4× 18 0.5× 19 151
Giovanna S. Manzano United States 6 88 1.1× 29 0.4× 126 2.0× 15 0.3× 17 0.4× 18 188
Guillaume Direz France 5 29 0.4× 131 2.0× 50 0.8× 36 0.8× 19 0.5× 7 253
F.–X. Borruat Switzerland 10 30 0.4× 43 0.7× 72 1.1× 51 1.2× 44 1.2× 28 291
Homayoun Roshanisefat Sweden 8 148 1.8× 50 0.8× 42 0.7× 22 0.5× 18 0.5× 12 200
Sharik Mustafa India 10 153 1.9× 75 1.1× 114 1.8× 7 0.2× 15 0.4× 14 183

Countries citing papers authored by Michaël Levraut

Since Specialization
Citations

This map shows the geographic impact of Michaël Levraut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Levraut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Levraut more than expected).

Fields of papers citing papers by Michaël Levraut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Levraut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Levraut. The network helps show where Michaël Levraut may publish in the future.

Co-authorship network of co-authors of Michaël Levraut

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Levraut. A scholar is included among the top collaborators of Michaël Levraut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Levraut. Michaël Levraut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Levraut, Michaël, et al.. (2025). The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis. Neurology and Therapy. 14(3). 711–731. 3 indexed citations
2.
Levraut, Michaël, Romain Marignier, Mikaël Cohen, et al.. (2025). Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti‐GFAP Antibodies. Annals of Clinical and Translational Neurology. 12(9). 1785–1793.
3.
Levraut, Michaël, Darin T. Okuda, Mikaël Cohen, et al.. (2024). The diagnostic value of the central vein sign in radiologically isolated syndrome. Annals of Clinical and Translational Neurology. 11(3). 662–672. 12 indexed citations
4.
Levraut, Michaël, Mikaël Cohen, Saskia Bresch, et al.. (2023). Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes. Neurology Neuroimmunology & Neuroinflammation. 10(6). 21 indexed citations
5.
Levraut, Michaël, Mikaël Cohen, Caroline Papeix, et al.. (2023). Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI. Revue Neurologique. 179(10). 1103–1110. 4 indexed citations
6.
Cohen, Mikaël, et al.. (2023). Early treatment with rituximab in Susac syndrome. Revue Neurologique. 180(3). 230–235.
7.
Levraut, Michaël, et al.. (2023). Diagnostic significance of antineutrophil cytoplasmic antibody (ANCA) titres: a retrospective case-control study. RMD Open. 9(2). e003113–e003113. 3 indexed citations
8.
Levraut, Michaël, Lydiane Mondot, Mikaël Cohen, et al.. (2022). Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities. Frontiers in Immunology. 13. 864133–864133. 9 indexed citations
9.
Crémoni, Marion, Vesna Brglez, Sylvia Benzaken, et al.. (2022). Air pollution exposure induces a decrease in type II interferon response: A paired cohort study. EBioMedicine. 85. 104291–104291. 9 indexed citations
10.
Levraut, Michaël, Olivier Camuzard, Thierry Balaguer, et al.. (2022). A role for metformin in the treatment of Dupuytren disease?. Biomedicine & Pharmacotherapy. 150. 112930–112930. 1 indexed citations
11.
Cohen, Mikaël, et al.. (2021). Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability. Multiple Sclerosis and Related Disorders. 54. 103144–103144. 28 indexed citations
12.
Levraut, Michaël, et al.. (2021). Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis. Frontiers in Immunology. 12. 673021–673021. 18 indexed citations
13.
Levraut, Michaël, Véronique Bourg, Philippe Cabre, et al.. (2021). Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report. Neurology and Therapy. 11(1). 507–513. 8 indexed citations
14.
Levraut, Michaël, et al.. (2021). Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion. Neurology and Therapy. 11(1). 499–505. 13 indexed citations
15.
Galland, J., et al.. (2020). Impact of Simulation-Based Learning on National Ranking Medical Examination Results in France. Simulation in Healthcare The Journal of the Society for Simulation in Healthcare. 15(4). 259–265. 2 indexed citations
16.
Levraut, Michaël, Laurence Legros, Marie C. Béné, et al.. (2020). Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study. Journal of Thrombosis and Thrombolysis. 50(4). 995–1003. 6 indexed citations
17.
Boutros, Jacques, Jonathan Benzaquen, Michaël Levraut, et al.. (2019). A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables. BMC Pulmonary Medicine. 19(1). 234–234. 4 indexed citations
18.
Levraut, Michaël, Mikaël Cohen, Saskia Bresch, et al.. (2019). Immunoglobulin G4-related hypertrophic pachymeningitis. Neurology Neuroimmunology & Neuroinflammation. 6(4). e568–e568. 39 indexed citations
19.
Bouhlel, L., et al.. (2018). Allergies aux anti-cancéreux. Revue française d'allergologie. 58(3). 182–184.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil Shuey Breakdown of academic impact, for papers by P. Vermersch Breakdown of academic impact, for papers by Yaser Al Malik Breakdown of academic impact, for papers by Stijn W. Genders Breakdown of academic impact, for papers by Carlo Asteggiano Breakdown of academic impact, for papers by Giovanna S. Manzano Breakdown of academic impact, for papers by Guillaume Direz Breakdown of academic impact, for papers by F.–X. Borruat Breakdown of academic impact, for papers by Homayoun Roshanisefat Breakdown of academic impact, for papers by Sharik Mustafa
Rankless by CCL
2026